Citadel Advisors - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$11,000
-92.7%
186,700
-79.3%
0.00%
Q2 2022$151,000
+31.3%
900,247
+267.7%
0.00%
Q1 2022$115,000
-56.1%
244,839
-46.8%
0.00%
Q4 2021$262,000
-63.6%
460,299
+6.2%
0.00%
Q3 2021$719,000
-0.6%
433,475
+0.1%
0.00%
Q2 2021$723,000
-44.8%
433,057
-44.1%
0.00%
Q1 2021$1,310,000
+108.3%
775,132
+96.0%
0.00%
Q4 2020$629,000
+229.3%
395,541
+97.4%
0.00%
Q3 2020$191,000
+130.1%
200,392
+53.9%
0.00%
Q2 2020$83,000
-27.2%
130,232
-52.2%
0.00%
Q1 2020$114,000
+12.9%
272,610
+57.3%
0.00%
Q4 2019$101,000
+21.7%
173,303
+3.5%
0.00%
Q3 2019$83,000
+18.6%
167,463
-7.5%
0.00%
Q2 2019$70,000
-27.1%
180,978
+5.9%
0.00%
Q1 2019$96,000
-35.1%
170,933
-54.4%
0.00%
Q4 2018$148,000
+43.7%
375,081
+85.1%
0.00%
Q3 2018$103,000
-60.4%
202,583
+71.2%
0.00%
Q2 2018$260,000
-68.1%
118,354
-50.7%
0.00%
Q1 2018$816,000
+43.2%
239,947
+71.3%
0.00%
Q4 2017$570,000
+1087.5%
140,095
+78.5%
0.00%
Q3 2017$48,000
-17.2%
78,504
-28.7%
0.00%
Q2 2017$58,000
+5.5%
110,048
+61.2%
0.00%
Q1 2017$55,000
+89.7%
68,266
+115.4%
0.00%
Q4 2016$29,000
+81.2%
31,700
+46.1%
0.00%
Q3 2016$16,000
-76.1%
21,700
-58.3%
0.00%
Q2 2016$67,000
-34.3%
52,040
+14.4%
0.00%
Q1 2016$102,000
+137.2%
45,487
+268.1%
0.00%
Q4 2015$43,000
-75.6%
12,356
-83.4%
0.00%
Q2 2015$176,000
-56.4%
74,468
+38.7%
0.00%
Q1 2015$404,000
+38.4%
53,672
-37.0%
0.00%
Q4 2014$292,000
-32.4%
85,153
-30.5%
0.00%
Q3 2014$432,000
-47.6%
122,443
+24.1%
0.00%
-100.0%
Q2 2014$824,000
+91.6%
98,691
+45.6%
0.00%0.0%
Q1 2014$430,000
+444.3%
67,771
+545.3%
0.00%
Q3 2013$79,00010,5020.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
CVA Family Office, LLC 1,173,200$1,865,0001.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$1,387,0000.82%
Cypress Capital Management LLC (WY) 214,575$341,0000.30%
Western Wealth Management, LLC 982,350$1,562,0000.23%
SRS Capital Advisors, Inc. 615,659$979,0000.14%
Willis Investment Counsel 1,213,053$1,929,0000.13%
Harvest Investment Services, LLC 124,423$197,0000.10%
Transform Wealth, LLC 205,481$327,0000.07%
COURIER CAPITAL LLC 379,973$604,0000.07%
BRIGHTON JONES LLC 398,912$634,0000.04%
View complete list of AMPIO PHARMACEUTICALS INC shareholders